Abbott Medical initiated a recall in July of 155,028 Proclaim and Infinity IPG models distributed in the US from 2015 through 2023 due to complaints from patients who are unable to exit the magnetic resonance imaging (MRI) mode.
The Food and Drug Administration has
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?